Z-1480-2025 Class II Ongoing
FDA device recall Z-1480-2025 was initiated by Stryker Corporation on Feb 25, 2025 and is designated Class II. Reason for recall: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal… The recall status is ongoing. Affected quantity: 182,344 total units.
Recall details
- Product Type
- Devices
- Report Date
- Apr 9, 2025
- Initiation Date
- Feb 25, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 182,344 total units
Product description
Nasopore 4cm Standard 2PK fragmentable nasal dressing, Catalog Number 5400-212-004S and Nasopore 4cm Firm 2PK Catalog Number 5400-222-004S
Reason for recall
There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.
Distribution pattern
US Nationwide distribution.
Code information
5400-212-004S UDI-DI: 07613327500387, Lot Numbers: 2024011914; 5400-222-004S UDI-DI: 07613327500479, Lot Numbers: 2024021212 2024052813
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1480-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026